Henkel Ag & Co (HELKF) 100.3000 $HELKF
Procter & Gamble starts Wella sales process
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 10:17AM CDT
REV: 36.11 (+0.11), COTY: 23.71 (-0.23), UL: 44.90 (-0.09), PG: 81.05 (+0.48)
Wal-Mart makes strategic laundry move
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 6:10AM CDT
WMT: 79.24 (+0.52), PG: 81.05 (+0.48)
MYOS Corporation Announces Appointment of Douglas Weekes as Chief Commercial Officer
Marketwire - Wed Jul 30, 7:04AM CDT
MYOS Corporation ("MYOS" or the "Company"

(NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, announced today that it has appointed Douglas Weekes as Chief Commercial Officer. Mr. Weekes will lead the Company's marketing, sales and product development of a portfolio of commercial products derived from the first clinically proven natural myostatin inhibitor, Fortetropin(TM). Positive clinical results have demonstrated that daily use of Fortetropin along with exercise may be beneficial to improving lean muscle mass, which has significant therapeutic effects for overall health including bone density, control of serum glucose, triglyceride levels and reduced inflammation. Mr. Weekes will lead the creation of several bionutrition products including bars, meal replacement formats and ready to drink beverages utilizing Fortetropin.
MYOS: 5.95 (+0.05)